As of Mar 27
| +0.15 / +0.26%|
The 16 analysts offering 12-month price forecasts for Merck have a median target of 63.50, with a high estimate of 72.00 and a low estimate of 57.00. The median estimate represents a +9.96% increase from the last price of 57.75.
The current consensus among 21 polled investment analysts is to Hold stock in Merck. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.